Vinay Saxena
Pediatric Hematology-Oncology · Mangonia Park, FLNPI 1366433211
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Pfizer at 30.4% of the total. Reporting peaked in 2019 at $11,609 and has fallen 76.7% since, to $2,706 in 2025. Among pediatric hematology-oncology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $235.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$8K
- Novartis$7K
- Octapharma USA, Inc.$4K
- E.r. Squibb & Sons, L.L.C.$1K
- Sanofi$1K
- Bristol Myers Squibb$963
- plus $4K from 25 others
Across 3 payments — averaging $4872.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Global Blood Therapeutics, Inc.$15K
What the payments were for
- Consulting fees$10,30540%
- Speaking & faculty fees$9,70037%
- Travel & lodging$2,66710%
- Food & beverage$3,24113%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 12 | $7,880 |
| Novartis | 10 | $7,433 |
| Octapharma USA, Inc. | 13 | $3,597 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,438 |
| Sanofi | 9 | $1,101 |
| Bristol Myers Squibb | 1 | $963 |
| AstraZeneca | 8 | $570 |
| Lantheus Medical Imaging, Inc. | 1 | $400 |
| BD | 1 | $400 |
| Beone Medicines Ltd. | 1 | $400 |
| Baxter Healthcare | 1 | $300 |
| Amgen | 3 | $254 |
| CSL Behring | 7 | $196 |
| Novo Nordisk | 7 | $162 |
| Agios Pharmaceuticals, Inc. | 5 | $102 |
| Genetix Biotherapeutics Inc | 4 | $99 |
| Servier Pharmaceuticals LLC | 3 | $73 |
| Springworks Therapeutics, Inc. | 3 | $70 |
| Adaptive Biotechnologies Corporation | 3 | $67 |
| Bayer | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Medunik USA Inc. | 2 | $48 |
| Sobi, Inc | 2 | $46 |
| Duchesnay USA Incorporated | 2 | $42 |
| Chiesi USA, Inc. | 1 | $38 |
| Fennec Pharmaceuticals, Inc. | 1 | $24 |
| RARE Disease Therapeutics, Inc. | 1 | $23 |
| USWM, LLC | 1 | $23 |
| Kedrion Biopharma, Inc. | 1 | $21 |
| Global Blood Therapeutics, Inc. | 1 | $21 |
| BTG International Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,913 in reported general payments places this provider in the 90th percentile of 132 pediatric hematology-oncology providers in Florida.
See all pediatric hematology-oncology providers in Florida →
Other pediatric hematology-oncology in Mangonia Park
- Guillermo DeanguloMiami$929K
- Shveta GuptaOrlando$714K
- Joanna DavisMiami$411K
- Fernando Corrales-MedinaMiami$335K
- Erin CockrellTampa$260K
- Jaime Libes-BanderOrlando$133K
- Neil GoldenbergSt Petersburg$106K
- Dana ObzutTampa$93K
- E Leila Jerome ClaySt Petersburg$75K
- Dennis Borrero RamosOrlando$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.